Home
About
Overview
Sharing Data
ORCID
Help
History (31)
RISC assembly defects in the Drosophila RNAi mutant armitage.
Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy.
Engagement of the Lewis X antigen (CD15) results in monocyte activation.
B cell response to fresh and effector T helper cells. Role of cognate T-B interaction and the cytokines IL-2, IL-4, and IL-6.
Measuring tumor mutation burden in cell-free DNA: advantages and limits.
See All 31 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Measuring tumor mutation burden in cell-free DNA: advantages and limits.
Addeo A, Weiss GJ. Measuring tumor mutation burden in cell-free DNA: advantages and limits. Transl Lung Cancer Res. 2019 Aug; 8(4):553-555.
View in:
PubMed
authors with profiles
Glen Weiss MD, MBA